PT  - JOURNAL ARTICLE
AU  - Blasco, María Luisa
AU  - Buesa, Javier
AU  - Colomina, Javier
AU  - Forner, María José
AU  - Galindo, María José
AU  - Navarro, Jorge
AU  - Noceda, José
AU  - Redón, Josep
AU  - Signes-Costa, Jaime
AU  - Navarro, David
TI  - Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia
AID  - 10.1101/2020.04.06.20052522
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.06.20052522
4099  - http://medrxiv.org/content/early/2020/04/08/2020.04.06.20052522.short
4100  - http://medrxiv.org/content/early/2020/04/08/2020.04.06.20052522.full
AB  - There is scarce information on the frequency of co-detection of respiratory pathogens (RP) in patients with Covid-19. Documentation of coinfections in Covid-19 pneumonia patients may be relevant for appropriate clinical and therapeutic management of patients. Between March 4th and March 28th, 2020, a total of 183 adult patients testing positive by SARS CoV-2 RT-PCR on respiratory specimens were hospitalized with interstitial pneumonia at our center, of whom 103 were tested for other RP by a multiplexed PCR assay. Three patients had a positive result for either one (n=2; Coronavirus HKU1 or Mycoplasma pneumoniae) or two targets (n=1; Influenza virus A (H3) and Respiratory syncytial virus B). Twenty-three patients testing negative by SARS CoV-2 RT-PCR and presentig with clinical, laboratory findings and imaging compatibe with Covid-19 pneumonia underwent RP screening. Of these, 6 (26%) had a positive result for a single RP. Our data indicate that despite the apparent rarity of coinfections in patients with Covid-19 pneumonia, routine testing for RP should be advised, since agents for which specific therapy can be prescribed may be detected.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe current work received no public or private funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to the nature of this research, participants of this study did not agree for their data to be shared publicly, so supporting data is not available.